Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier

Authors: Wenbin Tong, Li Sun, Jilan He, Shusen He, Fei Du

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Hepatitis B virus DNA was extracted from serum of a chronic carrier and polymerase chain reaction was performed on S gene. Direct sequencing showed a variant HBsAg with additional 4-amino acid insertion, and clone sequencing confirmed the mixture of variant HBsAg and wildtype HBsAg. Of 16 clones with 12-nucleotide insertion, 15 clones had identical AGAACAACACAA insertion between nucleotide 494 and nucleotide 495, and one clone had GGAACAACTCAA insertion in the same position plus 3-nucleotide deletion from nucleotide 491 to nucleotide 493. S114T, C121Y, T126S/A, Q129K, G130R, T131N, M133T, G145R, N146D substitution and premature stop codon were also found in those clones. However, the origin of HBV with 4-amino acid insertion in HBsAg was unclear.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: Hepatitis B vaccines. WER 2004, 79: 255-263. World Health Organization: Hepatitis B vaccines. WER 2004, 79: 255-263.
2.
go back to reference Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, et al.: Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27: 6550-6557. 10.1016/j.vaccine.2009.08.048PubMedCrossRef Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, et al.: Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27: 6550-6557. 10.1016/j.vaccine.2009.08.048PubMedCrossRef
3.
4.
go back to reference Stirk HJ, Thornton JM, Howard CR: A topological model for hepatitis B surface antigen. Intervirology 1992, 33: 148-158.PubMed Stirk HJ, Thornton JM, Howard CR: A topological model for hepatitis B surface antigen. Intervirology 1992, 33: 148-158.PubMed
5.
go back to reference Cooreman MP, Leroux-Roles G, Paulij WP: Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001, 8: 237-247. 10.1007/BF02256597PubMedCrossRef Cooreman MP, Leroux-Roles G, Paulij WP: Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001, 8: 237-247. 10.1007/BF02256597PubMedCrossRef
6.
go back to reference Chiou HL, Lee TH, Kao J, Mau YC, Ho MS: Altered antigenicity of 'α' determinant variants of hepatitis B virus. J Genl Virol 1997, 78: 2639-2645.CrossRef Chiou HL, Lee TH, Kao J, Mau YC, Ho MS: Altered antigenicity of 'α' determinant variants of hepatitis B virus. J Genl Virol 1997, 78: 2639-2645.CrossRef
7.
go back to reference Alexopoulou A, Dourakis SP: Genetic heterogeneity of hepatitis viruses and its clinical significance. Current Drug Targets - Inflammation & Allergy 2005, 4: 47-55. 10.2174/1568010053622867CrossRef Alexopoulou A, Dourakis SP: Genetic heterogeneity of hepatitis viruses and its clinical significance. Current Drug Targets - Inflammation & Allergy 2005, 4: 47-55. 10.2174/1568010053622867CrossRef
8.
go back to reference Waters JA, Kennedy M, Voet P, Hauser P, Carman W, Thomas HC: Loss of the common "a" determinant of hepatitis B surface antigen by vaccine-induced escape mutant. J Clin Invest 1992, 90: 2543-2547. 10.1172/JCI116148PubMedPubMedCentralCrossRef Waters JA, Kennedy M, Voet P, Hauser P, Carman W, Thomas HC: Loss of the common "a" determinant of hepatitis B surface antigen by vaccine-induced escape mutant. J Clin Invest 1992, 90: 2543-2547. 10.1172/JCI116148PubMedPubMedCentralCrossRef
9.
go back to reference Kreutz C: Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cel Mol Med 2002, 6: 113-143. 10.1111/j.1582-4934.2002.tb00317.xCrossRef Kreutz C: Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cel Mol Med 2002, 6: 113-143. 10.1111/j.1582-4934.2002.tb00317.xCrossRef
10.
go back to reference Carman WF, Zanetti AR, Karyiannis P, Waters J, Manzillo G, Tanzi E, Zuckermann A, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336: 325-329. 10.1016/0140-6736(90)91874-APubMedCrossRef Carman WF, Zanetti AR, Karyiannis P, Waters J, Manzillo G, Tanzi E, Zuckermann A, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336: 325-329. 10.1016/0140-6736(90)91874-APubMedCrossRef
11.
go back to reference Karthigesu VD, Allison L, Fortuin M, Mendy M, Whittle HC, Howard CR: A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994, 75: 443-448. 10.1099/0022-1317-75-2-443PubMedCrossRef Karthigesu VD, Allison L, Fortuin M, Mendy M, Whittle HC, Howard CR: A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994, 75: 443-448. 10.1099/0022-1317-75-2-443PubMedCrossRef
12.
go back to reference Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S: Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992, 32: 264-268. 10.1203/00006450-199209000-00002PubMedCrossRef Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S: Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992, 32: 264-268. 10.1203/00006450-199209000-00002PubMedCrossRef
13.
go back to reference Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y: Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996, 77: 1825-1831. 10.1099/0022-1317-77-8-1825PubMedCrossRef Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y: Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996, 77: 1825-1831. 10.1099/0022-1317-77-8-1825PubMedCrossRef
14.
go back to reference Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M: Naturally occurring escape mutants of hepatitis B virus with various mutations in the S Gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994, 68: 2671-2676.PubMedPubMedCentral Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M: Naturally occurring escape mutants of hepatitis B virus with various mutations in the S Gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994, 68: 2671-2676.PubMedPubMedCentral
15.
go back to reference Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R: Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995, 345: 1406-1407. 10.1016/S0140-6736(95)92599-6PubMedCrossRef Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R: Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995, 345: 1406-1407. 10.1016/S0140-6736(95)92599-6PubMedCrossRef
16.
go back to reference Hou JL, Karayiannis P, Waters J, Luo KX, Liang CS, Thomas HC: A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 1995, 21: 273-278.PubMed Hou JL, Karayiannis P, Waters J, Luo KX, Liang CS, Thomas HC: A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 1995, 21: 273-278.PubMed
17.
go back to reference Grethe S, Monazahian M, Bohme I, Thomssen R: Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 1998, 72: 7692-7696.PubMedPubMedCentral Grethe S, Monazahian M, Bohme I, Thomssen R: Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 1998, 72: 7692-7696.PubMedPubMedCentral
18.
go back to reference Echevarria J, Avellon A, Magnius L: Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 2005, 76: 176-184. 10.1002/jmv.20341PubMedCrossRef Echevarria J, Avellon A, Magnius L: Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 2005, 76: 176-184. 10.1002/jmv.20341PubMedCrossRef
19.
go back to reference Carman WF: The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepatitis 1997,4(S1):11-20. 10.1111/j.1365-2893.1997.tb00155.xCrossRef Carman WF: The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepatitis 1997,4(S1):11-20. 10.1111/j.1365-2893.1997.tb00155.xCrossRef
20.
go back to reference Ghany MG, Ayola B, Villamil FG, Gish RG, Tojter S, Vierling JM, Lok A: Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998, 27: 213-222. 10.1002/hep.510270133PubMedCrossRef Ghany MG, Ayola B, Villamil FG, Gish RG, Tojter S, Vierling JM, Lok A: Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998, 27: 213-222. 10.1002/hep.510270133PubMedCrossRef
21.
go back to reference Nakano T, Lu L, Hu XL, Mizokami M, Orito E, Shapiro CN, Hadler SC, Robertson BH: Characterization of hepatitis B virus genotypes among Yucpa Indians in Venezuela. J Gen Virol 2001, 82: 359-365.PubMedCrossRef Nakano T, Lu L, Hu XL, Mizokami M, Orito E, Shapiro CN, Hadler SC, Robertson BH: Characterization of hepatitis B virus genotypes among Yucpa Indians in Venezuela. J Gen Virol 2001, 82: 359-365.PubMedCrossRef
22.
go back to reference Zhou YH, Zhou JX, LI L, Bi YC, Liu Y, Pan JS, Wu C: A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs. J Clin Virol 2009, 46: 363-366. 10.1016/j.jcv.2009.09.012PubMedCrossRef Zhou YH, Zhou JX, LI L, Bi YC, Liu Y, Pan JS, Wu C: A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs. J Clin Virol 2009, 46: 363-366. 10.1016/j.jcv.2009.09.012PubMedCrossRef
23.
go back to reference Weber B, Bayer A, Kirch P, Schluter V, Schlirper D, Melchior W: Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 1999, 37: 2639-2647.PubMedPubMedCentral Weber B, Bayer A, Kirch P, Schluter V, Schlirper D, Melchior W: Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 1999, 37: 2639-2647.PubMedPubMedCentral
24.
go back to reference Mendy ME, McConkey SJ, Sande M, Crozier S, Kaye S, Jeffries D, Hall AD, Whittle HC: Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Virol J 2008, 5: 49. 10.1186/1743-422X-5-49PubMedPubMedCentralCrossRef Mendy ME, McConkey SJ, Sande M, Crozier S, Kaye S, Jeffries D, Hall AD, Whittle HC: Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Virol J 2008, 5: 49. 10.1186/1743-422X-5-49PubMedPubMedCentralCrossRef
25.
go back to reference Ashton-Rickardt PA, Murray K: Mutants of the hepatitis b virus surface antigen that define some antigenically essential residues in the immunodominant a region. J Med Virol 1989, 29: 196-203. 10.1002/jmv.1890290310PubMedCrossRef Ashton-Rickardt PA, Murray K: Mutants of the hepatitis b virus surface antigen that define some antigenically essential residues in the immunodominant a region. J Med Virol 1989, 29: 196-203. 10.1002/jmv.1890290310PubMedCrossRef
26.
go back to reference Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P: Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000, 60: 113-121. 10.1002/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0PubMedCrossRef Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P: Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000, 60: 113-121. 10.1002/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0PubMedCrossRef
27.
go back to reference Guestas ML, Mathet VL, Ruiz V, Minassian ML, Rivero C, Sala A, Corach D, Alessio A, Pozzati M, Frider B, Oubina JR: Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected Argentine patient with anti-HBs antibodies. J Clin Microbiol 2006, 44: 2191-2198. 10.1128/JCM.00057-06CrossRef Guestas ML, Mathet VL, Ruiz V, Minassian ML, Rivero C, Sala A, Corach D, Alessio A, Pozzati M, Frider B, Oubina JR: Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected Argentine patient with anti-HBs antibodies. J Clin Microbiol 2006, 44: 2191-2198. 10.1128/JCM.00057-06CrossRef
28.
go back to reference Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF: Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001, 33: 751-757. 10.1053/jhep.2001.22166PubMedCrossRef Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF: Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001, 33: 751-757. 10.1053/jhep.2001.22166PubMedCrossRef
29.
go back to reference Alexopoulou A, Baltayiannis G, Jammeh S, Waters J, Dourakis SP, Karayiannis P: Hepatitis B surface Antigen variant with multiple mutations in the α determinant in an Agammaglobulinemic patient. J Clin Microbiol 2004, 42: 2861-2865. 10.1128/JCM.42.6.2861-2865.2004PubMedPubMedCentralCrossRef Alexopoulou A, Baltayiannis G, Jammeh S, Waters J, Dourakis SP, Karayiannis P: Hepatitis B surface Antigen variant with multiple mutations in the α determinant in an Agammaglobulinemic patient. J Clin Microbiol 2004, 42: 2861-2865. 10.1128/JCM.42.6.2861-2865.2004PubMedPubMedCentralCrossRef
30.
go back to reference Wang RB, Kong J, Dali Wang DL, Lien L, Lien E: A survey of Chinese herbal ingredients with liver protection activities. Chinese Medicine 2007, 2: 5. 10.1186/1749-8546-2-5PubMedPubMedCentralCrossRef Wang RB, Kong J, Dali Wang DL, Lien L, Lien E: A survey of Chinese herbal ingredients with liver protection activities. Chinese Medicine 2007, 2: 5. 10.1186/1749-8546-2-5PubMedPubMedCentralCrossRef
31.
go back to reference Zhang LY, Wang GQ, Hou WH, Li P, Dulin A, Bonkovsky HL: Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 2010, 51: 690-698.PubMedPubMedCentralCrossRef Zhang LY, Wang GQ, Hou WH, Li P, Dulin A, Bonkovsky HL: Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 2010, 51: 690-698.PubMedPubMedCentralCrossRef
32.
go back to reference Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C: Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 1999, 180: 1444-1451. 10.1086/315094PubMedCrossRef Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C: Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 1999, 180: 1444-1451. 10.1086/315094PubMedCrossRef
33.
go back to reference Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR: The serology of chronic hepatitis B infection revisited. J Clin Invest 1993, 91: 2586-2595. 10.1172/JCI116497PubMedPubMedCentralCrossRef Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR: The serology of chronic hepatitis B infection revisited. J Clin Invest 1993, 91: 2586-2595. 10.1172/JCI116497PubMedPubMedCentralCrossRef
34.
go back to reference Kidd-Ljunggren K, Miyakawa Y, Kidd AH: Genetic variability in hepatitis B viruses. J Gen Virol 2002, 83: 1267-1280.PubMedCrossRef Kidd-Ljunggren K, Miyakawa Y, Kidd AH: Genetic variability in hepatitis B viruses. J Gen Virol 2002, 83: 1267-1280.PubMedCrossRef
35.
go back to reference Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY: Molecular Evolution of Hepatitis B Virus over 25 Years. J Virol 2006, 80: 10307-10314. 10.1128/JVI.00996-06PubMedPubMedCentralCrossRef Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY: Molecular Evolution of Hepatitis B Virus over 25 Years. J Virol 2006, 80: 10307-10314. 10.1128/JVI.00996-06PubMedPubMedCentralCrossRef
Metadata
Title
A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier
Authors
Wenbin Tong
Li Sun
Jilan He
Shusen He
Fei Du
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-104

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.